Patents by Inventor Alan D. Attie

Alan D. Attie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030064950
    Abstract: It is disclosed here that inhibiting the activity of the enzyme stearoyl-CoA desaturase (SCD1) in an animal causes the animal to have less body fat and greater lean body mass. The lower of SCD1 activity level can be accomplished by inhibiting activity of the enzyme or lowering levels of active enzyme in the subject.
    Type: Application
    Filed: March 8, 2002
    Publication date: April 3, 2003
    Inventors: James M. Ntambi, Alan D. Attie, Makoto Miyazaki, Jonathan P. Stoehr
  • Publication number: 20030013093
    Abstract: A gene expression pattern analysis has identified genes the expression patterns of which are different in adipose cells of individuals who have Type 2 Diabetes Mellitus from the cells of individuals who do not have the disease. This information provides a mechanism for the genetic diagnosis of the disease.
    Type: Application
    Filed: September 18, 2001
    Publication date: January 16, 2003
    Inventors: Alan D. Attie, Samuel T. Nadler
  • Patent number: 5521071
    Abstract: A truncation of the human LDL receptor gene has been created which can be expressed in a heterologous host to produce a soluble fragment to the receptor protein. The gene can be expressed in insect cells in culture to produce a protein fragment which is not only water soluble but which also retains affinity for binding to LDL. The truncation is a truncation of the carboxyl terminus of the native LDL receptor gene which results in a 354 amino acid protein fragment designated LDL-R.sup.354.
    Type: Grant
    Filed: April 15, 1994
    Date of Patent: May 28, 1996
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Alan D. Attie, Stephen L. Sturley, Daniel G. Gretch
  • Patent number: 5472858
    Abstract: A human lipid-associated plasma protein has been produced in vivo in larvae of the Sphingid insect tobacco hornworm, Manduca sexta. The gene for the protein was introduced by recombinant Baculovirus into the body cavity of the larvae, which is a semi-permissive host for the virus. After the larvae had grown further, the hemolymph of the larvae was recovered. The yield of protein produced was much better than could be achieved for the same gene expressed in insect cell culture and a much higher percentage of the protein produced in vivo was associated in lipid particles as compared to the cell culture system. The desired biological activity of the lipid-associated protein was achieved by the in vivo produced protein but not by the protein produced by insect cells in culture.
    Type: Grant
    Filed: June 4, 1991
    Date of Patent: December 5, 1995
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Alan D. Attie, Daniel G. Gretch, Stephen L. Sturley, Nancy E. Beckage